Cleerly ISCHEMIA vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by 4DMedical (Imbio CAC Software)

AI Verdict

Cleerly ISCHEMIA focuses on non-invasive detection of coronary artery ischemia and detailed plaque characterization using CCTA scans, aiding in personalized diagnosis and treatment planning. Imbio's CAC Software specializes in quantifying coronary artery calcification from non-contrast chest CTs, primarily for cardiovascular risk assessment. While both contribute to heart disease evaluation, Cleerly provides a more comprehensive assessment of vessel-level ischemia and plaque, whereas Imbio offers a focused, foundational measure of calcification.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease that goes beyond simple calcification scores. This tool is ideal for evaluating the likelihood of vessel-level ischemia, characterizing plaque volume and type, and assessing stenosis severity using CCTA scans to inform personalized treatment strategies. It provides a comprehensive understanding of both anatomical and functional aspects of coronary disease.

View Cleerly ISCHEMIA →

Choose CAC Software if…

Choose Imbio's CAC Software if your primary need is an automated and quantitative assessment of coronary artery calcification for cardiovascular risk stratification. This tool is particularly well-suited for analyzing non-contrast chest CT scans to generate an Agatston score, arterial age, and calcified lesion volume, integrating seamlessly into existing workflows for efficient initial risk assessment.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA CAC Software
Pricing Contact for details Unknown
Deployment Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) Cloud-based (SaaS), integrates with PACS
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Imbio CAC Software emphasizes a fully automated, 'no user input or intervention' process that integrates directly into existing DICOM viewing workflows and PACS, minimizing changes to a radiologist's routine. While Cleerly offers interactive web-based reports and PowerScribe integration, Imbio's approach prioritizes an effortless experience by making results available within the familiar PACS environment without requiring a separate interface to learn.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA offers significantly higher clinical value by non-invasively estimating fractional flow reserve (FFR) and characterizing plaque, directly assessing the likelihood of ischemia at a vessel level. This comprehensive analysis provides more actionable information for personalized diagnosis and treatment planning, including guiding revascularization decisions, and has demonstrated robust diagnostic accuracy and prognostic utility in clinical trials.

Pricing & Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA provides more transparency in its pricing, offering a retail price and mentioning a current discount, which gives potential users some insight into costs. Furthermore, its billability under a Category I CPT code (75580) suggests a clearer pathway for reimbursement, enhancing its value proposition for providers.

Enterprise Readiness

CAC Software

Imbio CAC Software demonstrates superior enterprise readiness with explicit offerings for Cloud, On-premise, and Partner platform deployment options. Its established partnerships with major healthcare IT vendors like Nuance, Siemens, and GE Healthcare further indicate a highly flexible and scalable solution capable of integrating into diverse enterprise environments.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA is more innovative as it pushes the diagnostic frontier by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA, directly assessing ischemia likelihood. This goes beyond the established practice of coronary artery calcification scoring offered by Tool B, providing a more advanced and comprehensive physiological assessment of heart disease.

Support & Docs

CAC Software

Imbio CAC Software offers superior support with documented 24/7/365 availability for all customers globally via phone and email, and recommends online case submission. While Cleerly provides support during business hours with after-hours priority, Imbio's round-the-clock accessibility and clear channels for requesting user manuals demonstrate a more robust and accessible support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA CAC Software
Name Cleerly ISCHEMIA CAC Software
Company Cleerly Imbio
Primary Analysis Focus Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level; coronary plaque characterization (volume, type, location) Automated image post-processing for coronary artery calcification; quantification of calcification within coronary arteries
Input Scan Type CCTA scans Non-contrast, chest computed tomography (CT)
Key Output Metrics Non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment Agatston score, arterial age, calcified lesion mass and volume
3D Visualization 3D digital models of coronary arteries 3D visualizations and annotated images
Integration Integration with PowerScribe via API Integrates into existing DICOM viewing workflow

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and CAC Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is designed to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. Imbio's CAC software focuses on quantifying the amount and location of calcification within the coronary arteries to support risk assessment for coronary artery disease.
Cleerly ISCHEMIA analyzes CCTA (Coronary CT Angiography) scans to provide its ischemia and plaque assessments. Imbio's CAC software utilizes non-contrast chest CT scans to calculate coronary artery calcification.
Cleerly ISCHEMIA provides vessel-level ischemia likelihood, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment. Imbio's CAC software outputs the Agatston score, arterial age, and calcified lesion mass and volume.
Yes, Cleerly ISCHEMIA offers comprehensive coronary plaque characterization, including volume, type, and location, in addition to stenosis severity assessment. Imbio's CAC software specifically focuses on quantifying calcification within the coronary arteries.
Yes, Cleerly ISCHEMIA provides 3D digital models of coronary arteries as part of its comprehensive interactive web-based reports. Imbio's CAC software also offers 3D visualizations and annotated images of calcification.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.